The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
Giovannoni, Gavin, Baker, David, Schmierer, KlausVolume:
4
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2014.11.005
Date:
January, 2015
File:
PDF, 397 KB
english, 2015